AGIO
Agios Pharmaceuticals, Inc.
31.30$
-1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -13.6% | -3.9% | +18.2% | -15.6% | +1.6% | -6.5% | -1.5% | +9.1% | -7.9% | +7.7% | -1.0% | – | |
| – | +52.2% | -33.2% | +25.2% | -3.6% | -2.2% | +4.2% | +29.3% | -15.8% | +14.1% | +10.0% | +2.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -617.6% | – | +347.9% | -202.0% | – | – | -102.8% | – | – | – | – | |
| – | -36.6% | -39.7% | +12.1% | +165.2% | +130.8% | -20.8% | +14.2% | +77.7% | -28.0% | -31.3% | +57.6% | – | |
| – | +142.8% | +30.4% | -70.1% | +573.4% | -119.6% | – | -29.9% | +21.0% | -5.7% | +56.9% | -71.5% | – | |
| – | -55.0% | +592.3% | -81.3% | +139.9% | +83.6% | -66.6% | -96.0% | +6,723.1% | -42.3% | -18.7% | +51.5% | – | |
| – | – | +28.0% | -212.1% | – | -204.9% | – | -29.8% | +520.8% | -130.2% | – | -157.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.